Thursday, August 20
Boursel
Latest
Personal Finance When driving across town for cheaper gas actually pays offTech OpenAI counters Anthropic with a no-retention approach to AI safety monitoringEconomy Trump pauses 50% tariffs as the US and Canada close in on a trade dealCompanies SpaceX sought to buy AI coding startup Cognition, Bloomberg reports; its CEO says noTech OpenAI slows some frontier AI work after a model nears a critical cyber thresholdCrypto Bitcoin tops $69,000, wiping out roughly $1.7 billion in short betsMarkets Gold jumps to its highest since early June as the Treasury doubles bond buybacksPersonal Finance Treasury moves to deny refundable tax credits to immigrants without qualified statusPersonal Finance When driving across town for cheaper gas actually pays offTech OpenAI counters Anthropic with a no-retention approach to AI safety monitoringEconomy Trump pauses 50% tariffs as the US and Canada close in on a trade dealCompanies SpaceX sought to buy AI coding startup Cognition, Bloomberg reports; its CEO says noTech OpenAI slows some frontier AI work after a model nears a critical cyber thresholdCrypto Bitcoin tops $69,000, wiping out roughly $1.7 billion in short betsMarkets Gold jumps to its highest since early June as the Treasury doubles bond buybacksPersonal Finance Treasury moves to deny refundable tax credits to immigrants without qualified status

Topic: fda

A scientist working in a research laboratory
Tech
Friday, 7/17, 07:32 AM

Kalshi Opens Betting on Drug Trials and FDA Decisions, Raising Insider Fears

  • Kalshi, the CFTC-regulated prediction-market exchange, has begun letting people bet on whether drug trials succeed and whether the FDA approves new medicines, outcomes that routinely move biotech stocks.
  • The company says safeguards protect trial integrity, but ethicists warn the contracts invite insider trading on confidential medical data, days after a separate Kalshi insider scandal.

In brief

fda — news and stories on this topic

This page collects all of Boursel's coverage of fda. Follow the topic from one place: new stories appear here automatically as more is published. That way you stay on top of how the situation develops.

Looking for the bigger picture? Browse markets, the economy, companies and crypto, or head back to the front page for the day's top stories.